Survival and Factors Associated with Survival with Extracorporeal Life Support During Cardiac Arrest: A Systematic Review and Meta-Analysis

Variability in patient selection criteria across extracorporeal cardiopulmonary resuscitation (ECPR) systems: A systematic review

BACKGROUND

Across the world, many systems have implemented extracorporeal cardiopulmonary resuscitation (ECPR) as a potential treatment strategy for patients in refractory cardiac arrest. To date, there are no universally accepted criteria for patient selection for ECPR. We conducted a systematic review to explore the variability in patient eligibility criteria for ECPR across systems.

METHODS

We searched the Cochrane Library(Wiley), EMBASE(OVID), and MEDLINE ALL (OVID) databases from inception to 5th February-2024 for all studies that described an ECPR system and where the system eligibility criteria was described. A combination of predetermined search terms was used to identify relevant articles. We conducted forward and backward citation tracking to identify any further relevant articles.

RESULTS

Our search identified 12,503 articles of which 167 articles were found to be potentially eligible. Seventy-seven articles were further excluded as they described the same ECPR system as another study. We finally included 90 studies describing a total of 93 ECPR systems. The eligibility criteria for ECPR differed among the included systems. Across systems, ECPR eligibility criteria included age (n=75, 80.7%), arrest witnessed status (n=64, 68.8%), any initial rhythm (n=55, 59.1%), and bystander CPR (n=33, 35.5%). Within criteria, we observed marked variability. The age cut-off varied from 50 to 80 years, with the most common age cut-off being 75 years and 18 (19.3%) systems having no cut-off. Whilst most systems limited ECPR to shockable rhythms (n=28,30.1%), some systems included shockable rhythms and/or PEA only (n=10,10.8%).

CONCLUSION

We observed marked variability across systems in the eligibility criteria for potential ECPR patients. There is a need for further work to identify the optimum ECPR selection criteria.

REVIEW REGISTRATION

PROSPERO (CRD42023451109).

Benefits, key protocol components, and considerations for successful implementation of extracorporeal cardiopulmonary resuscitation: a review of the recent literature

The application of venoarterial extracorporeal membrane oxygenation (ECMO) in patients unresponsive to conventional cardiopulmonary resuscitation (CPR) has significantly increased in recent years. To date, three published randomized trials have investigated the use of extracorporeal CPR (ECPR) in adults with refractory out-of-hospital cardiac arrest. Although these trials reported inconsistent results, they suggest that ECPR may have a significant survival benefit over conventional CPR in selected patients only when performed with strict protocol adherence in experienced emergency medical services-hospital systems. Several studies suggest that identifying suitable ECPR candidates and reducing the time from cardiac arrest to ECMO initiation are key to successful outcomes. Prehospital ECPR or the rendezvous approach may allow more patients to receive ECPR within acceptable timeframes than ECPR initiation on arrival at a capable hospital. ECPR is only one part of the system of care for resuscitation of cardiac arrest victims. Optimizing the chain of survival is critical to improving outcomes of patients receiving ECPR. Further studies are needed to find the optimal strategy for the use of ECPR.

The Year in Extracorporeal Membrane Oxygenation: Selected Highlights From 2021

This review summarizes the extracorporeal membrane oxygenation (ECMO) or extracorporeal life support literature published in 2021. This Selected Highlights article is not intended to be an exhaustive review of the literature, but rather a summarizing of key themes that developed in the ECMO literature during 2021. The primary topics presented include the following: ECMO for coronavirus disease 2019, extracorporeal cardiopulmonary resuscitation, periprocedural cardiopulmonary support with ECMO, and anticoagulation for ECMO.